Tamarack Advisers’s CVS Health CVS Stock Holding History

Tamarack Advisers’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,000	Closed	-$101K	–	46
2022 Q1	$101K	Buy	+1,000	New	+$105K	0.05%	44

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Tamarack Advisers's CVS Position: Q4 2022 in Review

Tamarack Advisers sold out of CVS Health (CVS) in Q4 2022, closing a stake of 50,000 shares — an estimated $4.77M sold.

Tamarack Advisers first reported a position in CVS in Q3 2017 and held it in 6 quarters. The position peaked at $16.9M in Q1 2021. 2,409 funds tracked by Wall St. Rank hold CVS as of Q4 2022.

Tamarack Advisers reported no remaining CVS Health position as of Q4 2022 after selling out during the quarter.
Tamarack Advisers sold 50,000 CVS Health shares in Q4 2022, an estimated $4.77M.
Tamarack Advisers first reported a position in CVS Health in Q3 2017 and held it in 6 quarters.
Tamarack Advisers's CVS Health position peaked at $16.9M in Q1 2021.
2,409 funds tracked by Wall St. Rank held CVS Health as of Q4 2022.

Based on Tamarack Advisers's 13F filing for Q4 2022, filed 13 Feb 2023.